Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Trainline flagged as potential private equity target amid attractive valuation and strong cash flow
Trainline flagged as potential private equity target amid attractive valuation and strong cash flow Trainline could soon find itself on the radar of private equity investors, according to analysts at Berenberg, who believe the market has priced the company too...
Inflexion seals £2.3bn continuation fund in Europe’s largest multi-asset GP-led deal
Inflexion seals £2.3bn continuation fund in Europe’s largest multi-asset GP-led deal Inflexion has announced the final close of its £2.3bn Inflexion Continuation Fund I, the largest multi-asset continuation fund raised in Europe to date. The oversubscribed vehicle...
CVC Capital’s Rolly van Rappard considers Milan move amid UK tax crackdown
CVC Capital’s Rolly van Rappard considers Milan move amid UK tax crackdown Rolly van Rappard, the billionaire co-founder of CVC Capital Partners, is reportedly weighing a move from London to Milan as the UK faces a rising exodus of ultra-wealthy residents responding...